01 6McCarthy Tétrault
01 22349330
02 22461202
03 22791171
01 6Apixaban
01 6Tablet
01 22019-12-17
02 22022-09-17
03 22031-02-24
Patent Expiration Date : 2022-09-17
Date Granted : 2011-07-12
Brand Name : ELIQUIS
Patent Number : 2461202
Filing Date : 2002-09-17
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-17
Date Granted : 2011-07-12
Patent Expiration Date : 2019-12-17
Date Granted : 2009-09-29
Brand Name : ELIQUIS
Patent Number : 2349330
Filing Date : 1999-12-17
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2009-09-29
Patent Expiration Date : 2019-12-17
Date Granted : 2009-09-29
Brand Name : ELIQUIS
Patent Number : 2349330
Filing Date : 1999-12-17
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2009-09-29
Patent Expiration Date : 2022-09-17
Date Granted : 2011-07-12
Brand Name : ELIQUIS
Patent Number : 2461202
Filing Date : 2002-09-17
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-17
Date Granted : 2011-07-12
Patent Expiration Date : 2031-02-24
Date Granted : 2017-08-29
Brand Name : ELIQUIS
Patent Number : 2791171
Filing Date : 2011-02-24
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2031-02-24
Date Granted : 2017-08-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-02-24
Date Granted : 2017-08-29
Brand Name : ELIQUIS
Patent Number : 2791171
Filing Date : 2011-02-24
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2031-02-24
Date Granted : 2017-08-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
